Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations (Q42742043)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 June 2006
edit
Language Label Description Also known as
English
Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations
scientific article published on 13 June 2006

    Statements

    Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations (English)
    1 reference
    Heather A Bradeen
    1 reference
    Christopher A Eide
    1 reference
    Thomas O'Hare
    1 reference
    Kara J Johnson
    1 reference
    Stephanie G Willis
    1 reference
    Francis Y Lee
    1 reference
    Michael W Deininger
    1 reference
    13 June 2006
    1 reference
    108
    1 reference
    2332-2338
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit